COVID-19 sensor in development with U.S. Army and DARPANews
March 04, 2021
ABERDEEN PROVING GROUND, Md. Army researchers joined an 18-month effort led by the Defense Advanced Research Projects Agency (DARPA) to identify and combine a suite of technologies that would form a stand-alone bio-aerosol monitor capable of detecting SARS-CoV-2.
The team consists of researchers from the U.S. Army Combat Capabilities Development Command, known as DEVCOM, Army Research Laboratory, Georgia Tech Research Institute, Cardea Bio, and the University of Georgia.
According to DARPA, the team’s ultimate goal is to develop a prototype sensor that can detect SARS-CoV-2 in the air with enough sensitivity, specificity, and speed to enable practical concepts of operation to be employed before infection can occur within an indoor environment.
DEVCOM claims that the laboratory will provide PCC receptors for SARS-CoV-2 produced over the past year in COVID response work. These receptors will be integrated into the sensor hardware through an active cooperative research and development agreement already established with Georgia Tech Research Institute.